This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers.

This information was originally presented on March 15, 2012, at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.
 

The molecular analysis of biomarkers in oncology is rapidly advancing, but the incorporation of new molecular tests into clinical practice will require a greater understanding of the genetic changes that drive malignancy, the assays used to measure the resulting phenotypes and genotypes, and the

This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers.

This information was originally presented on March 15, 2012, at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.